5.0
Nov 20, 2017
Recommend
CEO approval
Business outlook
Pros
great people, great technology, it was a very collaborative group that all worked well together. Everyone was excited by the technology
Cons
We ran into clinical difficulties in our phase 3 trial. I think some of the FDA requirements for combo products are very difficult to acheive